title: Tissue Engineering and Regenerative Medicine 2015: A Year in Review.
abstract: This may be the most exciting time ever for the field of tissue engineering and regenerative medicine (TERM). After decades of progress, it has matured, integrated, and diversified into entirely new areas, and it is starting to make the pivotal shift toward translation. The most exciting science and applications continue to emerge at the boundaries of disciplines, through increasingly effective interactions between stem cell biologists, bioengineers, clinicians, and the commercial sector. In this "Year in Review," we highlight some of the major advances reported over the last year (Summer 2014-Fall 2015). Using a methodology similar to that established in previous years, we identified four areas that generated major progress in the field: (i) pluripotent stem cells, (ii) microtissue platforms for drug testing and disease modeling, (iii) tissue models of cancer, and (iv) whole organ engineering. For each area, we used some of the most impactful articles to illustrate the important concepts and results that advanced the state of the art of TERM. We conclude with reflections on emerging areas and perspectives for future development in the field.
authors.affiliation: 1 Department of Biomedical Engineering, Columbia University , New York.
authors.forename: Holly
authors.initials: H
authors.lastname: Wobma
authors.affiliation: 1 Department of Biomedical Engineering, Columbia University , New York.|2 Department of Medicine, Columbia University , New York.
authors.forename: Gordana
authors.initials: G
authors.lastname: Vunjak-Novakovic
mesh_terms: D004353:Drug Evaluation, Preclinical; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000473:pathology; D039904:Pluripotent Stem Cells / Q000166:cytology; D044968:Regenerative Medicine / Q000379:methods*; D023822:Tissue Engineering / Q000379:methods*